Srivathsa Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.45 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.42 Cr
as on 17-07-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 17-07-2024
- Satisfied Charges ₹ 6.40 Cr
as on 17-07-2024
- Revenue 74.29%
(FY 2023)
- Profit 50.01%
(FY 2023)
- Ebitda 21.50%
(FY 2023)
- Net Worth 12.97%
(FY 2023)
- Total Assets 115.44%
(FY 2023)
About Srivathsa Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.45 Cr and a paid-up capital of Rs 3.42 Cr.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹6.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Buddaraju, Satyanarayana Chandu, Sri Addanki, and One other member serve as directors at the Company.
- CIN/LLPIN
U85190TG2008PTC060523
- Company No.
060523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Srivathsa Lifesciences Private Limited offer?
Srivathsa Lifesciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Srivathsa Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Buddaraju  | Director | 07-Aug-2008 | Current |
| Satyanarayana Chandu | Director | 07-Aug-2008 | Current |
| Sri Addanki | Director | 16-Feb-2017 | Current |
| Vijay Chandu | Director | 12-Jun-2019 | Current |
Financial Performance of Srivathsa Lifesciences.
Srivathsa Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.29% increase. The company also saw a substantial improvement in profitability, with a 50.01% increase in profit. The company's net worth Soared by an impressive increase of 12.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srivathsa Lifesciences?
In 2023, Srivathsa Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Dec 2021 | ₹10.00 Cr | Open |
Syndicate Bank Creation Date: 19 Jun 2015 | ₹3.37 Cr | Satisfied |
Canara Bank Creation Date: 28 Jul 2009 | ₹3.03 Cr | Satisfied |
How Many Employees Work at Srivathsa Lifesciences?
Srivathsa Lifesciences has a workforce of 50 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srivathsa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srivathsa Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
